Home » Topics » Regulatory

Regulatory
RSS

Positive phase III results for Actiza

Oct. 2, 2003

Approvable letter issued for Lexapro in GAD

Oct. 1, 2003

Integrin antagonists useful for angiogenesis-related ocular diseases

Sep. 30, 2003

Thyrogen indication extended in Europe

Sep. 30, 2003

FDA advisory committee recommends expanded label for Provigil

Sep. 30, 2003

Lumiracoxib approved by the MHRA for osteoarthritis and other indications

Sep. 25, 2003

New formulation of Singulair available for young children with asthma

Sep. 25, 2003

Six-month priority review granted for Eloxatin sNDA

Sep. 22, 2003

Eisai submits E.U. Pariet application for on-demand therapy of symptomatic GERD

Sep. 22, 2003

FDA approves expanded Synagis labeling for children with congenital heart disease

Sep. 19, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Medline raises $6.3B in fourth med-tech IPO of December
BioWorld MedTech
Medline Inc. returned to the public markets with a blockbuster IPO of $6.26 billion, reportedly this year’s largest IPO globally. The upsized offering of more...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
Vitesse finesse pays off: DBV wins in peanut allergy phase III
BioWorld
DBV Technologies SA’s pivotal phase III trial with the Viaskin Peanut allergy patch came through for the company, and officials plan a BLA filing with the U.S....
Acryl raises $28M IPO, aiming to bridge medical divide with AI
BioWorld MedTech
Acryl Inc. debuted on South Korea’s Kosdaq Dec. 16, raising ₩42.12 billion ($28.5 million) in an IPO. Shares (KOSDAQ:0007C0) closed at ₩67,000 on the first day,...